The World Health Organization/International Union Against Tuberculosis and Lung Disease Global Project on Surveillance for Anti-Tuberculosis Drug Resistance: a model for other infectious diseases.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Clinical Infectious Diseases

• Publication date

  2005-08-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1086/430786PMID 16032561
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study.

  2005cited by this paper
• Multidrug-resistant Mycobacterium tuberculosis in HIV-Infected Persons, Peru

  2003cited by this paper
• GUIDELINES FOR SURVEILLANCE OF DRUG RESISTANCE IN TUBERCULOSIS

  2003cited by this paper
• Worldwide incidence of multidrug-resistant tuberculosis.

  2002cited by this paper
• Involving private practitioners in tuberculosis control: issues, interventions, and emerging policy framework

  2001cited by this paper
• Investigation and control of a large outbreak of multi-drug resistant tuberculosis at a central Lisbon hospital.

  2001cited by this paper
• Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

  2001cited by this paper
• Private pharmacies and tuberculosis control: a survey of case detection skills and reported anti-tuberculosis drug dispensing in private pharmacies in Ho Chi Minh City, Vietnam.

  2000cited by this paper
• Human immunodeficiency virus-related tuberculosis and primary drug resistance in Bangkok, Thailand.

  2000cited by this paper
• Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

  1998cited by this paper
• An outbreak of multi-drug-resistant tuberculosis in a London teaching hospital.

  1998cited by this paper
• Anti-tuberculosis drug resistance in the world : the WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance

  1997cited by this paper
• Nosocomial spread of human immunodeficiency virus-related multidrug-resistant tuberculosis in Buenos Aires.

  1997cited by this paper
• Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis in Spain.

  1996cited by this paper
• A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes.

  1996cited by this paper
• Prevalence of drug resistance in Thai human immunodeficiency virus seropositive tuberculosis patients.

  1994cited by this paper
• Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis.

  1993cited by this paper
• The emergence of drug-resistant tuberculosis in New York City.

  1993cited by this paper
• World development report 1993 : investing in health

  1993cited by this paper
• Purchase of antibiotics without prescription in Manila, the Philippines. Inappropriate choices and doses.

  1990cited by this paper

• Detection Of Bronchial Tuberculosis Using ASFF-Yolov5S Model

  2023cites this paper
• The Role of Post-Bronchoscopy Sputum Examination in Screening for Active Tuberculosis

  2022cites this paper
• The simple direct slide method is comparable to indirect Lowenstein Jensen proportion culture for detecting rifampicin resistant tuberculosis.

  2021cites this paper
• Comparative Utility of Genetic Determinants of Drug Resistance and Phenotypic Drug Susceptibility Profiling in Predicting Clinical Outcomes in Patients With Multidrug-Resistant Mycobacterium tuberculosis

  2021cites this paper
• Association between serum PGE2 levels and degree of acid-fast bacilli positivity in sputum of pulmonary tuberculosis patients

  2021cites this paper
• People–centred care versus clinic–based DOT for continuation phase TB treatment in Armenia: a cluster randomized trial

  2020cites this paper
• Molecular Detection of Extra-pulmonary Tuberculosis by the Automated GeneXpert MTB/RIF Assay: 3-years’ experience in a teaching hospital, Saudi Arabia

  2019cites this paper
• Family-Based Tuberculosis Counseling Supports Directly Observed Therapy in Armenia: A Pilot Project

  2018influential citation
• Bronchoplasty for treating the whole lung atelectasis caused by endobronchial tuberculosis in main bronchus.

  2018cites this paper
• Antimycobacterial Agents: To Target or Not to Target

  2017cites this paper
• A New Second Messenger: Bacterial c-di-AMP.

  2016cites this paper
• An outbreak of multidrug-resistant tuberculosis among a family.

  2016cites this paper
• Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.

  2016cites this paper
• Liver Transplantation in Antituberculosis Drugs-Induced Fulminant Hepatic Failure

  2015cites this paper
• A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury

  2015cites this paper
• On the spread and control of MDR-TB epidemics: an examination of trends in anti-tuberculosis drug resistance surveillance data.

  2014cites this paper
• Dose of Incorporated Immunodominant Antigen in Recombinant BCG Impacts Modestly on Th1 Immune Response and Protective Efficiency against Mycobacterium tuberculosis in Mice

  2014cites this paper
• Expression and purification of cyto-insectotoxin (Cit1a) using silkworm larvae targeting for an antimicrobial therapeutic agent

  2014cites this paper
• High throughput screening of 7-methylpicene-1,2-diol as arylamine N-acetyltransferase (NAT) inhibitor to establish a isoniazid supplement in anti-tubercular therapy.

  2013cites this paper
• Conflicted cure: explorting concepts of default and adherence in drug resistant tuberculosis patients in Khayelitsha

  2013cites this paper
• Cyto-Insectotoxin 1a from Lachesana tarabaevi Spider Venom Inhibits Chlamydia trachomatis Infection

  2012cites this paper
• Evaluation of the clinical value of ELISA based on MPT64 antibody aptamer for serological diagnosis of pulmonary tuberculosis

  2012cites this paper
• Computational validation of 3-ammonio-3-(4-oxido- 1H-imidazol-1-ium-5-yl) propane-1, 1-bis (olate) as a potent anti-tubercular drug against mt-MetAP

  2012cites this paper
• Mycobacterium tuberculosis Rv3586 (DacA) Is a Diadenylate Cyclase That Converts ATP or ADP into c-di-AMP

  2012cites this paper
• Detection of IS6110 and HupB gene sequences of Mycobacterium tuberculosis and bovis in the aortic tissue of patients with Takayasu’s arteritis

  2012cites this paper
• From the Arm to the Test Tube: Laboratory's New Role in Tuberculosis Testing

  2012cites this paper
• Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010.

  2012cites this paper
• Outbreak of Bacille Calmette-Guérin-related lymphadenitis in Saudi children at a university hospital after a change in the strain of vaccine

  2012cites this paper
• The molecular epidemiology of Mycobacterium tuberculosis in north London

  2011cites this paper
• Modernizing Surveillance of Antituberculosis Drug Resistance: From Special Surveys to Routine Testing

  2011cites this paper
• High-resolution melting facilitates mutation screening of rpsL gene associated with streptomycin resistance in Mycobacterium tuberculosis.

  2011cites this paper
• La tuberculose multirésistante : extension, menace et solutions

  2011cites this paper
• Post-bronchoscopy sputum: improving the diagnostic yield in smear negative pulmonary TB.

  2011cites this paper
• [Multidrug resistant tuberculosis -- its extent, hazard and possible solutions].

  2011cites this paper
• Tuberculosis in Saudi Arabia: can we change the way we deal with the disease?

  2010cites this paper
• The Role of Rip2 Protein in the Nod Mediated Innate Immune Response: A Dissertation

  2010cites this paper
• "UTILIDAD DIAGNÓSTICA DEL QUANTIFERON-TB GOLD TEST IN TUBE ® EN LA INFECCIÓN TUBERCULOSA LATENTE Y EN LA ENFERMEDAD TUBERCULOSA EN EDAD PEDIÁTRICA"

  2010cites this paper
• Tuberculosis Prevalence in Forensic Autopsies

  2010cites this paper
• Non-pyogenic infections of the spine.

  2010cites this paper
• eview on-pyogenic infections of the spine

  2010cites this paper
• Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.

  2009cites this paper
• NOD2, RIP2 and IRF5 Play a Critical Role in the Type I Interferon Response to Mycobacterium tuberculosis

  2009cites this paper
• Ecological Conditions Affect Evolutionary Trajectory in a Predator-Prey System

  2009cites this paper
• Evaluation of the diagnostic utility of a whole blood interferon- γ assay for determining the risk of exposure to Mycobacterium tuberculosis in BCG-vaccinated individuals

  2009cites this paper
• Increasing pathomorphism of pulmonary tuberculosis: an observational study of slow clinical, microbiological and imaging response of lung tuberculosis to specific treatment. Which role for linezolid?

  2009cites this paper
• Latent Coinfection and the Maintenance of Strain Diversity

  2009cites this paper
• An outbreak of multidrug-resistant tuberculosis among refugees in Austria, 2005-2006.

  2008cites this paper
• Evaluation of the diagnostic utility of a whole-blood interferon-gamma assay for determining the risk of exposure to Mycobacterium tuberculosis in Bacille Calmette-Guerin (BCG)-vaccinated individuals.

  2008cites this paper
• External quality control of Mycobacterium tuberculosis drug susceptibility testing: results of two rounds in endemic countries.

  2008cites this paper
• Evaluation of new GenoType MTBDRplus for detection of resistance in cultures and direct specimens of Mycobacterium tuberculosis.

  2008cites this paper
• [Exposure to multiresisant tuberculosis: study and follow-up of nine children].

  2008cites this paper
• Exposición a tuberculosis multirresistente: estudio y seguimiento de nueve niños

  2008cites this paper
• Mycobacteriology Evaluation of the diagnostic utility of a whole-blood interferon-γ assay for determining the risk of exposure to Mycobacterium tuberculosis in Bacille Calmette-Guerin (BCG)-vaccinated individuals

  2008cites this paper
• Primary antimicrobial resistance among Mycobacterium tuberculosis isolates from HIV seropositive and HIV seronegative patients in Dar es Salaam Tanzania

  2008influential citation
• One-step purification and characterization of a fully active histidine-tagged Class II fructose-1,6-bisphosphate aldolase from Mycobacterium tuberculosis

  2008cites this paper
• Neutron scattering studies on dUTPase complex in the presence of bioprotectant systems

  2008cites this paper
• Epidemiology of laboratory confirmed tuberculosis in Victoria, 1990 to 2004.

  2008cites this paper
• Molecular epidemiology of drug-resistant tuberculosis in Sweden.

  2008cites this paper
• Gene expression profiling of suppressor mechanisms in tuberculosis.

  2008cites this paper
• Evaluation of an acid-fast bacilli autostainer for concentrated sputum smears.

  2008cites this paper
• Tuberculosis mutirresistente en la edad pediátrica

  2007cites this paper
• [Multidrug-resistant tuberculosis in the pediatric age group].

  2007cites this paper
• Silencing Mycobacterium smegmatis by using tetracycline repressors.

  2007cites this paper
• The Mycobacterium bovis BCG Cyclic AMP Receptor-Like Protein Is a Functional DNA Binding Protein In Vitro and In Vivo, but Its Activity Differs from That of Its M. tuberculosis Ortholog, Rv3676

  2007cites this paper
• Controlling multidrug-resistant tuberculosis in India – Authors' reply

  2007cites this paper
• THE ROLE OF THE MACROPHAGE IN LUNG DISEASE MEDIATED BY BACTERIA

  2007cites this paper
• Inhibition of mycobacterial arylamine N-acetyltransferase contributes to anti-mycobacterial activity of Warburgia salutaris.

  2007cites this paper
• Biological evaluation of pyrazinamide liposomes for treatment of Mycobacterium tuberculosis.

  2007cites this paper
• Silencing Essential Protein Secretion in Mycobacterium smegmatis by Using Tetracycline Repressors

  2007cites this paper
• 7.24 – Antimycobacterium Agents

  2007cites this paper
• Nucleotide-Binding Oligomerization Domain Protein 2-Deficient Mice Control Infection with Mycobacterium tuberculosis

  2007cites this paper
• Uma Rede Neuronal Para Diagnosticos em Pneumologia

  2007cites this paper
• Drug-resistant tuberculosis in Cuba. Results of the three global projects.

  2006cites this paper
• Characteristics of common infections in Nicaragua

  2006cites this paper
• Executive summary: select findings, conclusions, and policy recommendations.

  2005cites this paper
• Drug resistance among Tuberculosis Re-Treatment Cases; Study on Drug Resistance/Multi-drug Resistance and associated risk factors for developing MDR among Tuberculosis Re-Treatment Cases in Khartoum State

  2005cites this paper
• Factors Underlying the Success of the Mycobacterium tuberculosis Beijing genotype in Indonesia

  2003cites this paper